THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.

Guangxi Province People’s Republic of China (PRC) management prevention and control thalassemia

Journal

Hemoglobin
ISSN: 1532-432X
Titre abrégé: Hemoglobin
Pays: England
ID NLM: 7705865

Informations de publication

Date de publication:
Jan 2022
Historique:
entrez: 11 8 2022
pubmed: 12 8 2022
medline: 13 8 2022
Statut: ppublish

Résumé

Guangxi Province is located in the southwest of the People's Republic of China (PRC). The province has a population of 50.12 million with a birth rate of 13.31%. Thalassemia is a major health problem in Guangxi Province. About 20.0-25.0% of the population carries thalassemia genes, which is acknowledged to be the highest prevalence in China. National and provincial programs for thalassemia prevention and control have been introduced. Premarital screening and prenatal diagnosis (PND) for the prevention of thalassemic fetuses are available. Blood transfusions, iron chelation therapy, and stem cell transplantation are also available for transfusion-dependent thalassemic patients.

Identifiants

pubmed: 35950576
doi: 10.1080/03630269.2021.2008960
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-35

Auteurs

Ping Chen (P)

Key Laboratory of Thalassemia Research, Thalassemia Research Institute, Key Laboratory of Thalassemia Medicine, Chinese Academy of Medical Sciences, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.

Wei-Xiong Lin (WX)

Key Laboratory of Thalassemia Research, Thalassemia Research Institute, Key Laboratory of Thalassemia Medicine, Chinese Academy of Medical Sciences, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.

Shu-Qun Li (SQ)

Key Laboratory of Thalassemia Research, Thalassemia Research Institute, Key Laboratory of Thalassemia Medicine, Chinese Academy of Medical Sciences, First Affiliated Hospital of Guangxi Medical University, Nanning, People's Republic of China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH